Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Amand F. Schmidt; Lucy S. Pearce; John T. Wilkins; Juan P. Casas; Aroon D. Hingorani

doi:10.1136/heartjnl-2017-312858

Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Amand F. Schmidt^*, Lucy S. Pearce, John T. Wilkins, Juan P. Casas, Aroon D. Hingorani

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1053-1055
Number of pages	3
Journal	Heart
Volume	104
Issue number	13
DOIs	https://doi.org/10.1136/heartjnl-2017-312858
State	Published - 2018

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/heartjnl-2017-312858

Cite this

@article{fa01776881df45d1976ca111a5e4587a,

title = "Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease",

author = "Schmidt, {Amand F.} and Pearce, {Lucy S.} and Wilkins, {John T.} and Casas, {Juan P.} and Hingorani, {Aroon D.}",

note = "Funding Information: Health Sciences Fellow. ADH is an NIHR Senior Investigator and is funded by the UCL Hospitals NIHR Biomedical Research Centre. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed. data sharing statement All data are available at: http://www.cochrane.org/CD011748/VASC_pcsk9-inhibitors-prevention-cardiovascular-disease. {\textcopyright} Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Funding Information: funding AFS is funded by UCLH NIHR Biomedical",

year = "2018",

doi = "10.1136/heartjnl-2017-312858",

language = "English (US)",

volume = "104",

pages = "1053--1055",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "13",

}

TY - JOUR

T1 - Cochrane corner

T2 - PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

AU - Schmidt, Amand F.

AU - Pearce, Lucy S.

AU - Wilkins, John T.

AU - Casas, Juan P.

AU - Hingorani, Aroon D.

N1 - Funding Information: Health Sciences Fellow. ADH is an NIHR Senior Investigator and is funded by the UCL Hospitals NIHR Biomedical Research Centre. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed. data sharing statement All data are available at: http://www.cochrane.org/CD011748/VASC_pcsk9-inhibitors-prevention-cardiovascular-disease. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Funding Information: funding AFS is funded by UCLH NIHR Biomedical

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85048337179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048337179&partnerID=8YFLogxK

U2 - 10.1136/heartjnl-2017-312858

DO - 10.1136/heartjnl-2017-312858

M3 - Editorial

C2 - 29444808

AN - SCOPUS:85048337179

SN - 1355-6037

VL - 104

SP - 1053

EP - 1055

JO - Heart

JF - Heart

IS - 13

ER -

Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this